卵巢癌细胞和脐血树突状细胞融合瘤苗的体外培养与免疫原性的研究

首都医科大学学报 ›› 2007, Vol. 28 ›› Issue (5): 604-608.

卵巢癌细胞和脐血树突状细胞融合瘤苗的体外培养与免疫原性的研究

李金凤, 张震宇, 王淑珍, 刘晋玮

首都医科大学附属北京朝阳医院妇产科

收稿日期:2007-01-17 修回日期:1900-01-01 出版日期:2007-10-24 发布日期:2007-10-24
通讯作者: 张震宇

The Anti-tumor Immunity and Cultivation of the Fused Cells of Ovarian Cancer and Dendritic Cells Derived from Cord Blood——An In-vitro Study

Li Jinfeng, Zhang Zhenyu, Wang Shuzhen, Liu Jinwei

Department of Obstertrics and Gynecology, Beijing Chaoyang Hospital, Capital Medical University

Received:2007-01-17 Revised:1900-01-01 Online:2007-10-24 Published:2007-10-24

摘要/Abstract

摘要： 目的将脐血来源的树突状细胞(DC)与人卵巢癌细胞株SKOV3细胞相融合,获得SKOV3/DC融合细胞,分析其生物学特性及其免疫原性。方法 ①利用PKH₂6红色荧光染料标记脐血来源的DC,用聚乙二醇法(PEG)融合DC与人卵巢癌细胞株SKOV3细胞,用流式细胞仪分选融合细胞(SKOV3/DC)。②应用细胞培养技术、流式细胞术及光学显微镜检测SKOV3/DC的生长特性和形态学特征,并分析其免疫原性。结果 ①脐血来源的单核细胞(Mo)在相关细胞因子的作用下,可诱导分化为DC,其可表达表面抗原CD1a、CD80、CD86、HLA-DR及MHC-Ⅰ,不表达CA125。②人卵巢癌细胞株SKOV3细胞为CA125及MHC-Ⅰ双阳性细胞,不表达CD1a、CD80、CD86和HLA-DR分子。③树突状细胞和SKOV3按10∶1比例融合,融合率约为8.5%。SKOV3/DC形态与亲本肿瘤细胞相似,CA125抗原表达呈阳性,并且高表达CD1a、CD80、CD86、HLA-DR和MHC-Ⅰ分子。SKOV3/DC在体外能分裂增殖,但增殖活性明显低于SKOV3细胞。结论 ①脐血中的DC前体细胞(单核细胞)可在体外分化扩增为成熟的功能性DC。②SKOV3/DC融合细胞兼具两种亲本细胞的部分特性,但其体外增殖活性明显降低,失去亲本肿瘤的恶性生长特性。本研究为将SKOV3/DC作为肿瘤疫苗用于卵巢癌主动免疫治疗的研究提供了前期资料。

关键词: 肿瘤疫苗, 树突状细胞, 卵巢癌, 融合细胞, 抗肿瘤免疫

Abstract: Objective To prepare hybrid cells(SKOV3/DC) by fusion of dendritic cells(DC) derived from cord blood and SKOV3 ovarian cancer cells; and analyze the biological characteristics and anti-tumor immunity of SKOV3/DC.Methods ① DC cells stained with PKH₂6 red fluorescence were fused with SKOV3 by means of polyethyleneglycol(PEG), and the fusion cells(SKOV3/DC) were selected with flow cytometry. ② Techniques of cell culture、flow cytometry and light microscopy were also used in characterization of growth, morphology and immunology of SKOV3/DC in vitro.Results ① The monocytes isolated from cord blood could be induced to DC. DC expressed CD1a, CD80, CD86, HLA-DR, MHC-Ⅰ molecules, but not CA125 antigen. ② SKOV3 cells expressed CA125 antigen and MHC-Ⅰ molecule but not CD1a, CD80, CD86 and HLA-DR molecules. ③ The DC were fused with SKOV3 cells at a ratio of 10∶1 and the fusion rate was about 8.5%.The morphological character of the SKOV3/DC was similar to its parental cells. SKOV3/DC express both CA125 antigen and high levels of CD1a, CD80, CD86, HLA-DR, MHC-Ⅰ molecules. SKOV3/DC could divide and proliferate in vitro, but the proliferative activity was significantly lower as compared with SKOV3 cells.Conclusion ① DC precursors in cord blood could be induced to differentiate and mature in media containing different cytokines. ② SKOV3/DC have some characteristics of both parental cells. The ability of dividsion and proliferation is significantly decreased as compared with SKOV3 cells, and the characteristic of malignant growth of parental SKOV3 cells has been lost. These data about SKOV3/DC vaccine found a basis for the study of the immunotherapy for ovarian cancer.

Key words: tumor vaccine, dendritic cells, ovarian cancer, fusion cells, anti-tumor immunity

中图分类号:

Q781

李金凤;张震宇;王淑珍;刘晋玮. 卵巢癌细胞和脐血树突状细胞融合瘤苗的体外培养与免疫原性的研究[J]. 首都医科大学学报, 2007, 28(5): 604-608.

Li Jinfeng;Zhang Zhenyu;Wang Shuzhen;Liu Jinwei. The Anti-tumor Immunity and Cultivation of the Fused Cells of Ovarian Cancer and Dendritic Cells Derived from Cord Blood——An In-vitro Study[J]. Journal of Capital Medical University, 2007, 28(5): 604-608.

[1]	王文文, 蔡昱, 贾双双, 翟建军. 驱动蛋白家族成员2C与卵巢癌化学药物治疗耐药的相关性[J]. 首都医科大学学报, 2023, 44(1): 143-147.
[2]	刘群, 李丽娜, 刘健, 苗劲蔚. 卵巢癌SOX4介导TGF-β1诱导的上皮间质转化对侵袭转移能力的影响[J]. 首都医科大学学报, 2022, 43(3): 336-342.
[3]	张紫欣, 孟颖, 梁宇霆. 双模态对比剂Fe₃O₄-Cy5.5-NGR在卵巢癌的体外靶向效能研究[J]. 首都医科大学学报, 2018, 39(1): 84-91.
[4]	陈晨, 孟艳. 血管紧张素Ⅱ对树突状细胞功能的影响[J]. 首都医科大学学报, 2017, 38(5): 709-714.
[5]	王明星, 王燕, 赵京霞, 底婷婷, 阮智通, 蒙玉娇, 谢湘江, 张璐, 林燕, 王宁, 李萍. 树突状细胞在咪喹莫特诱导的银屑病样小鼠模型中的表达及凉血解毒方的干预作用[J]. 首都医科大学学报, 2017, 38(2): 249-259.
[6]	刘晨, 吴龙, 蒋宏传, 李杰, 刘军, 王淑珍. 乳腺癌术后并发妇科生殖道恶性肿瘤的高危因素分析[J]. 首都医科大学学报, 2017, 38(1): 92-96.
[7]	丁翔;李红霞. 卵巢癌组织中鸟氨酸脱羧酶基因过度扩增及其临床意义[J]. 首都医科大学学报, 2009, 30(3): 289-292.
[8]	王晶;赵灵芝;克晓燕. 制备淋巴瘤多基因肿瘤疫苗的方法学探索[J]. 首都医科大学学报, 2008, 29(2): 118-123.
[9]	杨磊;刘复强;王景文;吴轶萍;丁璟. 亚硒酸钠对树突状细胞体外增强CTL杀伤K562细胞作用的研究[J]. 首都医科大学学报, 2008, 29(2): 137-141.
[10]	魏薇;沈铿;赵丽红;曹阳. Fischer344大鼠上皮性卵巢癌动物模型的建立[J]. 首都医科大学学报, 2007, 28(1): 52-55.
[11]	何焱玲;齐焕英;徐俊珠;董洁. 体外诱导培养人树突状细胞的生物学特性及其神经免疫调节功能分析[J]. 首都医科大学学报, 2006, 27(6): 712-715.
[12]	张海萍;连石;朱威. 梅毒患者外周血单核细胞体外诱导树突状细胞的形态学与功能研究[J]. 首都医科大学学报, 2006, 27(6): 727-729.
[13]	林宇庚;张震宇;王立生;吴彬. 野生型p53,GM-CSF和B7-1基因转移对卵巢癌细胞系SKOV-3增生的影响[J]. 首都医科大学学报, 2005, 26(5): 588-592.
[14]	徐婷婷;Hinda J. Ahmed;Kristina Eriksson;Karin Ahlman;杨永弘;Teresa Lagergard. 杜克雷嗜血杆菌与人类树突状细胞和巨噬细胞体外的相互作用[J]. 首都医科大学学报, 2004, 25(2): 193-197.
[15]	冯瑞娥;李敬军;王军梅;赵同建. 乳腺癌组织中S-100蛋白阳性树突状细胞的研究[J]. 首都医科大学学报, 1997, 18(4): 324-326.